Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 mutations – with manageable side effects,…

Continue ReadingTargeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

MASLD in children linked to increased mortality and chronic complications

Researchers from University of California San Diego have found that children diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD) are at significantly increased risk of premature death and serious long-term…

Continue ReadingMASLD in children linked to increased mortality and chronic complications

Health care providers working together as ACOs save Medicare billions over long term

Teams of health care providers called Accountable Care Organizations participating in the Medicare Shared Savings Program have saved Medicare between $4.1 billion and $8.1 billion from 2012 through 2019, according…

Continue ReadingHealth care providers working together as ACOs save Medicare billions over long term